
Anirudh Eminent Accretion Private Limited
About Anirudh Eminent Accretion Private Limited
Data last updated:
Anirudh Eminent Accretion Private Limited is a private limited company based in Chandigarh, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the dentalcare segment of the healthcare sector. It was incorporated on 23 May 2011.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74900CH2011PTC032976.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amar Nath Bansal and Ravinder Nath Bansal.
Its last annual general meeting (AGM) was held on 21 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at # 134 Sector 44 – A, Chandigarh, India – 160047.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.35 Lakh, a decline of 57% compared to the previous year. For the same year it recorded a net loss of ₹387 (net margin -0.2%) and EBITDA of ₹22,555 (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Company details
Contact details
Anirudh Eminent Accretion Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address# 134 Sector 44 – A, Chandigarh, India – 160047
- IndustryHealthcare, Dentalcare, Nursing, Pathology
To see the full contact details of Anirudh Eminent Accretion Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anirudh Eminent Accretion is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Anirudh Eminent Accretion Private Limited, buy the company report.
Financials of Anirudh Eminent Accretion Private Limited
FY 2019 filings availableAnirudh Eminent Accretion Private Limited reported revenue of ₹2.35 Lakh (down 57% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 57% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 402% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,555 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹387 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anirudh Eminent Accretion Private Limited, buy the company report.
Board of directors of Anirudh Eminent Accretion Private Limited
Anirudh Eminent Accretion has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Nath Bansal | Director | 23 May 2011 | 15 Years 5 Months | Current |
| Ravinder Nath Bansal | Director | 23 May 2011 | 15 Years 5 Months | Current |
Peer comparison
Anirudh Eminent Accretion Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fyddol Polyclinic Private Limited | ₹2.48 Lakh (FY 2020) | Delhi, India | ||||
| Neptune Diagnostic Centre Private Limited | ₹2.45 Lakh (FY 2025) | 54.0% | Thane, Maharashtra, India | |||
| Equacure Healthcare Private Limited | ₹2.41 Lakh (FY 2023) | Araria, Bihar, India | ||||
| Ivory Oral Care Private Limited | ₹2.41 Lakh (FY 2025) | 2836.0% | Delhi, India | |||
| Priyanka Body Revolutions Private Limited | ₹2.37 Lakh (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Anirudh Eminent Accretion Private Limitedthis company | ₹2.35 Lakh (FY 2019) | -₹387 | -0.2% | -57.0% | Chandigarh, India | |
| Winlife Hospitals Limited | ₹2.32 Lakh (FY 2023) | -77.0% | Chennai, Tamil Nadu, India | |||
| Dhanwanthari Speciality Labs Private Limited | ₹2.3 Lakh (FY 2020) | -70.0% | Rajahmundry, Andhra Pradesh, India | |||
| Dental Ceramists Zubler Private Limited | ₹2.25 Lakh (FY 2019) | 34.0% | Mumbai, Maharashtra, India | |||
| Cell Diagnostics and Research Private Limited | ₹2.2 Lakh (FY 2024) | -60.0% | Kolkata, West Bengal, India | |||
| Excel Dental Lab Private Limited | ₹2.17 Lakh (FY 2021) | -77.0% | New Delhi, Delhi, India |
To see the full peer comparison of Anirudh Eminent Accretion Private Limited, buy the company report.
Auditor
Anirudh Eminent Accretion Private Limited is audited by SUKHPREET NAZAKAT AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUKHPREET NAZAKAT AND ASSOCIATES | FY 2017 | 017507N |
Shareholding
The shareholding of Anirudh Eminent Accretion Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Anirudh Eminent Accretion Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anirudh Eminent Accretion Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anirudh Eminent Accretion Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Anirudh Eminent Accretion Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Anirudh Eminent Accretion Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Amar Nath Bansal was appointed as Director on 23 May 2011.
Frequently asked questions
Anirudh Eminent Accretion is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Anirudh Eminent Accretion is a company pending strike off, currently registered as a private limited company based in Chandigarh, India. The company works in dentalcare, within the healthcare industry. It was incorporated on 23 May 2011 and is registered under CIN U74900CH2011PTC032976. The company may be struck off soon - caution is advised.
The compliance status of Anirudh Eminent Accretion is compliant as of 25 August 2026.
Anirudh Eminent Accretion has 2 current directors:
- Amar Nath Bansal - Director
- Ravinder Nath Bansal - Director
The CIN (Corporate Identification Number) of Anirudh Eminent Accretion is U74900CH2011PTC032976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anirudh Eminent Accretion was incorporated on 23 May 2011. It is registered with the Registrar of Companies, Chandigarh.
The registered office of Anirudh Eminent Accretion is at # 134 Sector 44 – A, Chandigarh, India – 160047.
The latest financial statements of Anirudh Eminent Accretion on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 21 September 2019. Year-wise statements from 2015 are in the company report.
Anirudh Eminent Accretion operates in the healthcare industry, in the dentalcare segment.
The peers of Anirudh Eminent Accretion by revenue are Fyddol Polyclinic Private Limited, Neptune Diagnostic Centre Private Limited, Equacure Healthcare Private Limited, Ivory Oral Care Private Limited, Priyanka Body Revolutions Private Limited and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Amar Nath Bansal was appointed as Director on 23 May 2011. Ravinder Nath Bansal was appointed as Director on 23 May 2011.

